| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.27▲ | 6.31▼ | 6.34▼ | 6.25▲ | 6.11▲ |
| MA10 | 6.27▼ | 6.35▼ | 6.39▼ | 6.21▲ | 6.06▲ |
| MA20 | 6.33▼ | 6.38▼ | 6.33▼ | 6.08▲ | 5.85▲ |
| MA50 | 6.35▼ | 6.26▲ | 6.26▲ | 5.95▲ | 6.51▼ |
| MA100 | 6.27▼ | 6.22▲ | 6.19▲ | 5.71▲ | 7.63▼ |
| MA200 | 6.25▲ | 6.10▲ | 5.72▲ | 6.18▲ | 6.66▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.026▼ | -0.018▼ | 0.027▲ | 0.115▲ |
| RSI | 39.594▼ | 43.096▼ | 46.801▼ | 55.195▲ | 51.386▲ |
| STOCH | 26.501 | 6.910▼ | 26.274 | 68.201 | 41.128 |
| WILL %R | -80.000▼ | -90.164▼ | -71.429 | -37.079 | -50.000 |
| CCI | -48.087 | -134.946▼ | -101.841▼ | 99.232 | 59.550 |
|
Tuesday, January 14, 2020 05:00 AM
LEXINGTON, Mass.--(Business Wire)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives ...
|
|
Thursday, September 05, 2019 05:00 PM
A look at the shareholders of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership.
|
|
Tuesday, June 25, 2019 04:14 AM
Aldeyra Therapeutics (NASDAQ:ALDX) is poised for a significant down move this morning after announcing that a Phase 3 clinical trial, SOLACE, evaluating reproxalap in patients with noninfectious ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/01/20 | 6.45 | 6.519 | 6.24 | 6.26 | 114,300 |
| 16/01/20 | 6.36 | 6.57 | 6.36 | 6.40 | 157,400 |
| 15/01/20 | 6.23 | 6.30 | 6.07 | 6.25 | 177,700 |
| 14/01/20 | 6.19 | 6.22 | 6.01 | 6.19 | 119,400 |
| 13/01/20 | 6.30 | 6.30 | 6.05 | 6.15 | 125,900 |
| 10/01/20 | 6.29 | 6.36 | 6.13 | 6.23 | 166,447 |
| 09/01/20 | 6.30 | 6.40 | 6.11 | 6.23 | 196,000 |
| 08/01/20 | 6.24 | 6.37 | 6.08 | 6.30 | 259,800 |
| 07/01/20 | 5.88 | 6.27 | 5.86 | 6.19 | 210,447 |
| 06/01/20 | 5.82 | 5.97 | 5.70 | 5.89 | 178,400 |
|
|
||||
|
|
||||
|
|